Introduction 88
The prevalence of overweight and obesity is rising rapidly, not only in the adult global 89 population but also in children and adolescents, and type 2 diabetes mellitus (T2DM) is 90 increasingly observed in children [1] [2] [3] . Recent studies have suggested that the offspring of 91 families with diabetes are at increased risk of overweight and the development of T2DM 92 during their lifetimes, potentially in response to in utero exposure to hyperglycemia in a 93 mother with gestational diabetes mellitus (GDM) or type 1 diabetes mellitus (T1DM) or to 94 shared genetic factors [4] [5] [6] [7] [8] . 95 In such high-risk children, changes in lifestyle behavior that might prevent overweight, 96 T2DM, and comorbidities such as cardiovascular diseases appear highly relevant [1] . In Anthropometric measurements 157 At each visit in both studies, weight and height were assessed with the same standardized 158 protocols. Height was measured without shoes using a stadiometer with a precision of ± 1 159 mm, and weight was measured digitally or with a beam scale with a precision of ± 100 g, in 160 light clothing. Height and weight were used to calculate the body mass index (BMI, kg/m 2 ), 161 which was then transformed into age-and sex-adjusted z-scores and classified into percentiles 162 according to German reference data [22] . Children at or above the 90th and 97th percentiles 163 were defined to be overweight and obese, respectively. Diastolic and systolic blood pressures 164 were measured as the average of two measurements using an auscultatory or oscillometric 165 method in the upper arm while sitting, and were transformed into age-, sex-, and height-166 adjusted z-scores according to German reference data [23] . In TEENDIAB, Tanner's staging 167 was assessed by the study doctor or local pediatrician using validated questionnaires [24] .
168
Blood markers 169 The oral glucose tolerance test (OGTT) was performed at the study center after overnight 170 fasting. The study participants ingested a glucose solution containing 1.75 g of glucose per kg 171 bodyweight, or 75 g at maximum. Blood samples were collected at 0, 30, 60, 90, and 120 172 minutes after ingestion to determine the blood glucose, insulin, and C-peptide levels. were transformed into standardized z-scores, which were used for all analyses to avoid any 193 bias caused by the dissimilarity of the devices. The associations between the MVPA z-scores 194 and potential confounders, such as age and sex, were investigated with Spearman's 195 correlation coefficient (r) or a t test (as appropriate).
196
For interleukin readings below the detection limit, half the observed minimum value was 
Results

214
The baseline characteristics of the study population (n = 234) are described in Table 1 . 215 Overall, 143 (61.1%) study participants were exposed to hyperglycemia during pregnancy 216 (i.e., to GDM in POGO and to T1DM in TEENDIAB), and the remaining 91 (38.9%) had a (p = 0.001). The MVPA z-scores were not significantly associated with the seasonality of the 229 measurement (p = 0.51), a family history of diabetes (p = 0.48), or the BMI z-score 230 (r = −0.03, p = 0.62).
231
In the pooled analysis, the MVPA z-scores were significantly associated with insulin 232 sensitivity measured as ISI (β [95% CI] = 0.75 [0.15, 1.35], p = 0.01 in the fully adjusted 233 model), but not with insulin resistance (assessed as HOMA-IR or IGI), blood pressure, or 234 lipids ( Table 2) . Although there was no significant association between daily MVPA and 235 fasting insulin, increasing MVPA z-scores were associated with significantly lower values for 236 insulin during OGTT challenge (e.g., β [95% CI] = −6.42 [−11.13, −1.71], p = 0.008, after 237 120 minutes in the fully adjusted model; Table 3 ). Similarly, MVPA was not significantly 238 associated with fasting C-peptide, but significantly associated with it at 60-120 minutes 239 during challenge (e.g., β [95% CI] = −1.69 [−3.26, −0.12], p = 0.04, after 120 minutes in the 240 fully adjusted model). Higher MVPA tended to be associated with lower blood glucose during 241 challenge, but not significantly. Therefore, the mean patterns of glucose, insulin, and C-242 peptide levels during OGTT challenge were higher in the study participants with low physical 243 activity than in those with average or high physical activity ( Figure 2 ). No significant 244 associations between the MVPA z-scores and cytokine levels were observed (Table 4 ). Most 245 associations were similar in the TEENDIAB and POGO subjects, and were robust to stepwise 246 adjustment.
247
The effect estimates did not change markedly after the exclusion of the actibelt® 248 measurements or after adjustment for the Tanner stage in TEENDIAB (data not shown). We 249 observed no meaningful interactions between MVPA and sex or age with respect to any 250 outcome variable. to previously published results [18, 19] , we found no significant associations between MVPA 270 and cytokine levels.
271
A particular strength of our data is that physical activity was assessed with accelerometers.
272
Accelerometry is an objective method of measuring physical activity and tends to yield more 273 precise results in children and adolescents than subjective methods of physical activity 274 assessment [36]. Furthermore, MVPA was assessed within a few days of the visit at which the 275 anthropometric parameters and biomarkers were measured. The internal validity of these 276 measurements is likely to be high because they were performed with standardized protocols 277 that were identical in the two studies. When we considered the external generalizability of our 278 data, it was surprising that the percentage of overweight and obese participants (11.4%) in this 279 seemingly high-risk study population was lower than in the average German population (4-10 280 years old, 14.9% [37]; 11-17 years old, 18.9% [38]), and that the daily time spent in MVPA 281 seemed relatively high. Our data covered a broad age range of MVPA measurements, and we 282 accommodated potential age-and sex-specific differences in both MVPA and all the outcome 283 variables.
284
However, several limitations must be noted. For internal reasons, we used two different 285 accelerometers whose outputs are not directly comparable because they do not measure the Tables 2-4) . Therefore, our study should be seen as mainly exploratory.
305
Furthermore, we were unable to exclude potential confounding by factors such as maternal 306 socioeconomic status because such variables were not available in our data. Lastly, we cannot 307 infer causality from our observations because we did not have prospective measurements of 308 MVPA, but could only assess cross-sectional associations.
309
In conclusion, our findings indicate that the promotion of physical activity may benefit 310 children and adolescents with a family history of diabetes by lowering their insulin and C-311 peptide under OGTT challenge. However, we found no evidence of a similar protective effect 312 of physical activity on other anthropometric or metabolic markers in these subjects. Table 3 . Regression coefficients from linear regression models of MVPA z-scores (predictor variables) and blood glucose, insulin, and C-peptide levels during OGTT challenge (outcome variables) with stepwise adjustment for age, sex (model 1), age-and sex-specific BMI z-score (model 2), and season of accelerometry measurement (model 3), according to study (POGO or TEENDIAB) and pooled. Pooled models were also adjusted for study affiliation. Bold font indicates significant associations (p < 0.05). Table 4 . Regression coefficients from linear regression models of MVPA z-scores (predictor variables) and cytokines (outcome variables per pg/ml, log-transformed) with stepwise adjustment for age, sex, and storage time (model 1), age-and sex-specific BMI z-score (model 2), and season of accelerometry measurement (model 3), according to study (POGO or TEENDIAB) and pooled. Pooled models were also adjusted for study affiliation. In POGO, only IL-6 and IL-10 were measured. Bold font indicates significant associations (p < 0.05).
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